← Open Payments lookup

CHERYL-LISA BENNETT: Open Payments

NPI 1649394461 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,879 in 46 payments from 9 companies in 2025. Trend: 2023 $1,296 · 2024 $747 · 2025 $1,879

Food & beverage: $1,879
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc9$493
E.R. Squibb & Sons, L.L.C.12$456
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$352
Otsuka America Pharmaceutical, Inc.8$269
Teva Pharmaceuticals USA, Inc.5$140
Lundbeck LLC3$79
Alkermes, Inc.2$50
Luye Pharma (USA) Ltd.1$22
Neurocrine BioSciences, Inc.1$17

Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, REXULTI, AUSTEDO XR, ABILIFY MAINTENA, ARISTADA, ERZOFRI EXTENDED-RELEASE.

Industry payments across NY — which companies pay providers there.